Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
FASEB J ; 34(1): 399-409, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-31914606

RESUMEN

The liver plays a key role during fasting to maintain energy homeostasis and euglycemia via metabolic processes mainly orchestrated by the insulin/glucagon ratio. We report here that fasting or calorie restriction protocols in C57BL6 mice promote a marked decrease in the hepatic protein levels of G protein-coupled receptor kinase 2 (GRK2), an important negative modulator of both G protein-coupled receptors (GPCRs) and insulin signaling. Such downregulation of GRK2 levels is liver-specific and can be rapidly reversed by refeeding. We find that autophagy, and not the proteasome, represents the main mechanism implicated in fasting-induced GRK2 degradation in the liver in vivo. Reducing GRK2 levels in murine primary hepatocytes facilitates glucagon-induced glucose production and enhances the expression of the key gluconeogenic enzyme Pck1. Conversely, preventing full downregulation of hepatic GRK2 during fasting using adenovirus-driven overexpression of this kinase in the liver leads to glycogen accumulation, decreased glycemia, and hampered glucagon-induced gluconeogenesis, thus preventing a proper and complete adaptation to nutrient deprivation. Overall, our data indicate that physiological fasting-induced downregulation of GRK2 in the liver is key for allowing complete glucagon-mediated responses and efficient metabolic adaptation to fasting in vivo.


Asunto(s)
Adaptación Biológica/efectos de los fármacos , Autofagia , Ayuno , Quinasa 2 del Receptor Acoplado a Proteína-G/metabolismo , Glucagón/farmacología , Hígado/metabolismo , Animales , Quinasa 2 del Receptor Acoplado a Proteína-G/genética , Fármacos Gastrointestinales/farmacología , Homeostasis , Hígado/efectos de los fármacos , Hígado/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Transducción de Señal
2.
Cell Mol Life Sci ; 77(23): 4957-4976, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31927610

RESUMEN

Macrophages are key effector cells in obesity-associated inflammation. G protein-coupled receptor kinase 2 (GRK2) is highly expressed in different immune cell types. Using LysM-GRK2+/- mice, we uncover that a reduction of GRK2 levels in myeloid cells prevents the development of glucose intolerance and hyperglycemia after a high fat diet (HFD) through modulation of the macrophage pro-inflammatory profile. Low levels of myeloid GRK2 confer protection against hepatic insulin resistance, steatosis and inflammation. In adipose tissue, pro-inflammatory cytokines are reduced and insulin signaling is preserved. Macrophages from LysM-GRK2+/- mice secrete less pro-inflammatory cytokines when stimulated with lipopolysaccharide (LPS) and their conditioned media has a reduced pathological influence in cultured adipocytes or naïve bone marrow-derived macrophages. Our data indicate that reducing GRK2 levels in myeloid cells, by attenuating pro-inflammatory features of macrophages, has a relevant impact in adipose-liver crosstalk, thus preventing high fat diet-induced metabolic alterations.


Asunto(s)
Tejido Adiposo/metabolismo , Dieta Alta en Grasa , Quinasa 2 del Receptor Acoplado a Proteína-G/metabolismo , Hígado/metabolismo , Células Mieloides/metabolismo , Obesidad/metabolismo , Adipocitos/efectos de los fármacos , Adipocitos/metabolismo , Adipocitos/patología , Tejido Adiposo Blanco/patología , Animales , Medios de Cultivo Condicionados/farmacología , Citoprotección/efectos de los fármacos , Hígado Graso/complicaciones , Hígado Graso/patología , Microbioma Gastrointestinal/efectos de los fármacos , Glucosa/metabolismo , Intolerancia a la Glucosa/metabolismo , Hipertrofia , Inflamación/patología , Insulina/metabolismo , Resistencia a la Insulina , Macrófagos Peritoneales/efectos de los fármacos , Macrófagos Peritoneales/metabolismo , Ratones Endogámicos C57BL , Modelos Biológicos , Células Mieloides/efectos de los fármacos , Obesidad/complicaciones , Transducción de Señal/efectos de los fármacos , Aumento de Peso/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA